2813-6934

Frontiers in Lupus

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 57 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact57 DOIs
2

Add abstracts to 5 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact5 DOIs
3

Deposit reference lists for 3 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact3 DOIs

DOIs for this ISSN

Showing the top 5 of 57 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The 330 risk loci known for systemic lupus erythematosus (SL… (10.3389/flupu.2024.1398035)
ORCID
37.63 31
2 A critical role for IFN-β signaling for IFN-κ induction in k… (10.3389/flupu.2024.1359714)
ORCID
30.10 15
3 Disease activity assessment in systemic lupus erythematosus (10.3389/flupu.2024.1442013)
ORCID
25.00 9
4 Modeling of horizontal pleiotropy identifies possible causal… (10.3389/flupu.2023.1234578)
ORCID
23.86 8
5 Insights into future management of lupus nephritis (10.3389/flupu.2024.1334932)
ORCID
22.58 7
6 Editorial: Rheumatology education without borders—a global a… (10.3389/flupu.2025.1540588)
Abstract References ORCID
22.58 1
7 Preterm birth, preeclampsia, gestational hypertension and of… (10.3389/flupu.2024.1375857)
ORCID
17.47 4
8 Enhancing systemic lupus erythematosus care and outcomes thr… (10.3389/flupu.2024.1462320)
ORCID
17.47 4
9 Impact of race and ethnicity on family participation in syst… (10.3389/flupu.2023.1100534)
ORCID
15.05 3
10 Increased carotid intima–media thickening and antioxidized l… (10.3389/flupu.2023.1197309)
ORCID
15.05 3
11 Placental lesions in patients with antiphospholipid antibody… (10.3389/flupu.2024.1459172)
ORCID
15.05 3
12 Sub-optimal use of anti-malarial therapy for SLE in the Asia… (10.3389/flupu.2024.1461739)
ORCID
15.05 3
13 Pregnancy planning in lupus and APS patients (10.3389/flupu.2024.1479881)
ORCID
15.05 3
14 Monoclonal antibodies targeting type 2 inflammation in eosin… (10.3389/flupu.2024.1479884)
ORCID
15.05 3
15 Lupus-associated NCF2 variant p.R395W in the NADPH oxidase 2… (10.3389/flupu.2023.1186641)
ORCID
11.93 2
16 Osteonecrosis is associated with APOL1 variants in African A… (10.3389/flupu.2023.1219277)
ORCID
11.93 2
17 A non-coding variant in SLC15A4 modulates enhancer activity… (10.3389/flupu.2023.1244670)
ORCID
11.93 2
18 Microfibrillar-associated protein 4 interaction with inflamm… (10.3389/flupu.2024.1386256)
ORCID
11.93 2
19 Motherhood and rheumatic disease – a balancing act. A qualit… (10.3389/flupu.2024.1497518)
ORCID
11.93 2
20 Postnatal health of infants born to mothers with autoimmune… (10.3389/flupu.2025.1480867)
ORCID
11.93 2
21 Undifferentiated connective tissue disease with an incidenta… (10.3389/flupu.2023.1223001)
ORCID
7.53 1
22 Insights into maternal and neonatal anti-Ro/SSA antibodies:… (10.3389/flupu.2024.1358121)
ORCID
7.53 1
23 Educational priorities for primary care providers on systemi… (10.3389/flupu.2024.1446335)
ORCID
7.53 1
24 High fetal risk in pregnancies of myositis patients—a Hungar… (10.3389/flupu.2024.1449390)
ORCID
7.53 1
25 Challenging cases in rheumatic disease pregnancy: management… (10.3389/flupu.2024.1455456)
ORCID
7.53 1
26 Comparative efficacy and safety of belimumab and hydroxychlo… (10.3389/flupu.2024.1459949)
ORCID
7.53 1
27 Ataxic sensory neuronopathy with isolated anti-Ro/SS-A antib… (10.3389/flupu.2024.1461157)
ORCID
7.53 1
28 Strengthening lupus education and coordinated care in develo… (10.3389/flupu.2024.1462111)
ORCID
7.53 1
29 Low-dose aspirin in systemic lupus erythematosus pregnancy:… (10.3389/flupu.2024.1470870)
ORCID
7.53 1
30 Differences in gestational age at preterm birth can predict… (10.3389/flupu.2025.1473368)
ORCID
7.53 1
31 Clinical and histopathological features of lupus nephritis a… (10.3389/flupu.2025.1604644)
ORCID
7.53 1
32 Scavenger receptors: key players in the immunological puzzle… (10.3389/flupu.2025.1679564)
ORCID
7.53 1
33 Postpartum challenges in women with systemic autoimmune dise… (10.3389/flupu.2026.1788752)
ORCID
7.53 1
34 Case Report: Overlap syndrome of relapsing polychondritis an… (10.3389/flupu.2024.1334214)
ORCID
0.00 0
35 Development of The Lupus Clinical Trials Enrollment Decision… (10.3389/flupu.2024.1373534)
ORCID
0.00 0
36 Serum isolevuglandin IgG antibody concentrations are increas… (10.3389/flupu.2024.1377164)
ORCID
0.00 0
37 Corrigendum: Microfibrillar-associated protein 4 interaction… (10.3389/flupu.2024.1432884)
Abstract References ORCID
0.00 0
38 Editorial: Advancements and challenges in epidemiology of lu… (10.3389/flupu.2024.1439486)
Abstract ORCID
0.00 0
39 Editorial: New insights into interferons and proinflammatory… (10.3389/flupu.2024.1465771)
Abstract References ORCID
0.00 0
40 Insights into pregnancy risks associated with active juvenil… (10.3389/flupu.2024.1471435)
Abstract ORCID
0.00 0
41 Case Report: Crosstalk between systemic lupus erythematosus… (10.3389/flupu.2024.1484352)
ORCID
0.00 0
42 Altered hemostatic balance in favor of a procoagulant state… (10.3389/flupu.2024.1511382)
ORCID
0.00 0
43 Rheumatic autoimmune disease in relation to post-traumatic s… (10.3389/flupu.2025.1553510)
ORCID
0.00 0
44 Sjögren's disease and systemic lupus erythematosus overlap:… (10.3389/flupu.2025.1600768)
ORCID
0.00 0
45 Immune dysregulation and lipid interactions in systemic lupu… (10.3389/flupu.2025.1607792)
ORCID
0.00 0
46 Evaluating CXCR6 and its ligand CXCL16 as biomarkers for lup… (10.3389/flupu.2025.1645416)
ORCID
0.00 0
47 Case Report: Biologic-free clinical remission following anif… (10.3389/flupu.2025.1737535)
ORCID
0.00 0
48 Evaluating the efficacy of SK1217 in attenuating pristane-in… (10.3389/flupu.2026.1466123)
ORCID
0.00 0
49 Cardiovascular risk in systemic lupus erythematosus: beyond… (10.3389/flupu.2026.1725054)
ORCID
0.00 0
50 The urgent need for randomized controlled trials in pregnant… (10.3389/flupu.2026.1747204)
ORCID
0.00 0